• SENSEX 73,922.26
    -304.82 (--0.41%)
  • BANKNIFTY 50,511.00
    650.90 (+1.31%)
  • Tata Motors
    585.30 542.55(%)
  • Hind.Aeronautics
    3,970.00 3,045.95(%)
  • Reliance Industr
    1,169.10 1,115.55(%)
  • Vodafone Idea
    7.03 6.60(%)
  • Dixon Technolog.
    12,773.20 7,100.05(%)
  • Eternal Ltd
    210.55 146.85(%)
  • Adani Green
    852.75 758.00(%)
  • Mazagon Dock
    2,290.80 1,046.00(%)
  • Suzlon Energy
    51.75 37.95(%)
  • Tata Steel
    125.35 122.60(%)
  • Infosys
    1,381.35 1,307.10(%)
  • Siemens
    2,673.50 2,271.44(%)
  • Ramkrishna Forg.
    782.05 1,064.00(%)
  • Northern ARC
    169.60 153.50(%)
  • Wipro
    235.10 208.40(%)
  • Rajoo Engineers
    140.50 332.93(%)
  • TCS
    3,215.90 3,060.25(%)
  • Quadrant Future
    515.30 367.00(%)
  • Jio Financial
    218.50 198.60(%)
  • T R I L
    518.30 650.23(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Shilpa Medicare Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5031.0
  • ISIN : INE790G01031
642.55 33 (5.40%)
  • As on 09 Apr 2025 (EOD)

  • Today’s Low

    610.05

  • Today’s High

    649.70

  • Open

    624.40

  • Perv Close

    609.65

  • 52W Low

    417.60

  • 52W High

    959.50

Key Indicators

  • P/E(TTM)

    103.63

  • Mar.Cap (₹Cr.)

    6,283.55

  • Div & Yield %

    0.00

  • Book Value(₹)

    275.24

  • Debt-Equity Ratio

    5.40

  • AGM Date

    08-Apr-2025

  • EPS

    6.21

  • P/E Ratio

    103.63

Financials Ratios

  • Debt-Equity Ratio

    0.48

  • Mar.Cap (₹Cr.)

    6,283.55

  • RONW (%)

    1.72

  • ROCE (%)

    5.16

Score Board

  • Equity (₹ in Cr.)

    9.78

  • BV (₹)

    275.20

  • Sales( ₹ in Cr.)

    309.79

  • NP (in Cr.)

    33.87

  • NP Var(%)

    -54.0

  • Div%

    0.0

  • CPS (₹)

    8.50

  • EPS (₹)

    3.50

  • Traded Value (₹ in Lakhs)

    6,293.33

  • 52 Week High

    959.50

  • 52 Week Low

    417.60

  • Price BSE

    644.0

  • Price NSE

    643.00

  • Market Capital( in Cr.)

    6,293.33

  • P/C Ratio

    75.40

  • P/E Ratio

    185.90

  • Price Vs.BV

    3.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 309.79 247.70 356.95 257.05 805.97 663.88
Excise Duty 183.39 203.37 322.36 235.49 707.25 621.13
Net Sales 309.79 247.70 356.95 257.05 805.97 663.88
Other Income 89.12 68.64 40.86 32.25 11.26 15.53
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 398.90 316.35 397.81 289.30 817.23 679.41
EXPENDITURE :
Raw Materials 183.39 203.37 322.36 235.49 707.25 621.13
Power & Fuel Cost 183.39 203.37 322.36 235.49 707.25 621.13
Employee Cost 103.64 109.54 110.57 76.10 149.28 124.66
Other Manufacturing Expenses 6.81 2.95 -0.57 3.43 7.95 10.98
Selling & Administrative Expenses 49.74 60.03 106.22 55.92 67.02 39.32
Miscellaneous Expenses 6.81 2.95 -0.57 3.43 7.95 10.98
Less : Pre-operative Expenses Capitalised :
Total Expenditure 350.36 359.08 379.14 252.03 600.35 512.14
Operating Profit 34.05 36.98 40.26 29.13 71.25 65.50
Interest 17.26 20.83 9.05 6.07 4.33 2.79
Gross Profit 38.09 -58.28 27.49 90.21 212.34 173.50
Depreciation 49.61 46.55 34.82 22.28 34.96 34.01
Profit Before Tax 38.09 -58.28 27.49 90.21 212.34 173.50
Tax 11.29 -8.37 4.80 15.78 39.09 40.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.13 -0.43 2.53 9.34 5.05 -2.76
Reported Net Profit 26.94 -49.48 20.16 65.09 168.19 135.75
Extraordinary Items 38.09 -58.28 27.49 90.21 212.34 173.50
Adjusted Net Profit 26.94 -49.48 20.16 65.09 168.19 135.75
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 106.68 120.83 119.30 25.52 -17.90
Statutory Appropriations 0.00 0.00 9.55 8.97 8.97 8.15
P & L Balance carried down 26.94 -49.48 20.16 65.09 168.19 135.75
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 110.00 110.00 110.00 100.00
Dividend Per Share(Rs) 0.00 0.00 1.10 1.10 1.10 1.00
Earnings Per Share-Unit Curr 3.10 6.59 16.87 22.61 23.76 15.22
Book Value 0.00 0.00 9.55 8.97 8.97 8.15
Book Value(Adj)-Unit Curr 0.00 0.00 9.55 8.97 8.97 8.15

Shareholding Pattern

  • Promoter Group

    44.23%

  • Public Share Holding

    55.77%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 43,249,715 44.23 43,249,715 23
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 43,249,715 44.23 43,249,715 23
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 502 0.00 502 2
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,500 0.00 1,500 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 9,684,668 9.90 9,684,668 92
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,814,740 1.86 1,814,740 2
Mutual Funds / UTI 4,786,504 4.89 4,786,504 8
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,483,266 1.52 1,483,266 9
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 17,771,180 18.17 17,771,180 114
2] Non Institution
Bodies Corporate 11,006,792 11.26 11,006,792 548
Clearing Members 234 0.00 234 4
Directors of their Relatives 31,077 0.03 31,077 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 785,973 0.80 785,973 934
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 801,265 0.82 801,265 1,137
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,903,385 8.08 7,903,385 14
Individuals holding nominal share capital up to Rs. 1 lakh 15,952,879 16.31 15,796,615 46,253
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,157 0.00 2,157 3
Others 286,251 0.29 286,251 2
Sub Total 36,770,013 37.60 36,613,749 48,897
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 97,790,908 100.00 97,634,644 49,034

Company Background

Shilpa Medicare LtdPharmaceuticals - Indian - Formulations

  • Shilpa Medicare Ltd
  • BSE Code : 5031.0
  • ISIN : INE790G01031

  • Incorporation Year

    1987

  • Registered Office

    #12-6-214/A1
    Hyderabad Road, Raichur,
    Karnataka-584135

  • Telephone

    91-8532-238704

  • FAX

    91-8532238876

  • Chairman

    Omprakash Inani

  • Managing Director

    Vishnukant Bhutada

  • Company Secretary

    Ritu Tiwary

  • Auditor

    Bohara Bhandari Bung And Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Shilpa Medicare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Shilpa Medicare 643.55 398.90 309.79 111.15 2.77
Abbott India 29,413.45 6,097.18 5,848.91 46.84 44.71
Astrazeneca Phar 8,061.90 1,330.33 1,295.53 207.83 33.26
P & G Health Ltd 5,104.95 1,166.89 1,151.26 35.82 39.76
Glaxosmi. Pharma 2,728.95 3,530.73 3,407.25 54.26 44.44
Cipla 1,433.45 17,645.00 16,574.34 24.57 20.10
Amrutanjan Healt 629.40 437.58 421.23 36.89 20.84
Fermenta Biotec. 271.05 315.24 307.09 25.69 4.10
Guj. Themis Bio. 253.25 174.19 169.82 52.43 44.82
Bliss GVS Pharma 120.15 638.96 605.46 27.49 11.19
Ambalal Sarabhai 36.60 11.70 3.81 15.64 1.92